Point-of-Care Measurements of Platelet Inhibition After Clopidogrel Loading in Patients With Acute Coronary Syndrome: Comparison of Generic Clopidogrel Bisulfate (Plavitor®) With Original Clopidogrel Bisulfate (Plavix®)

• Status: Completed
• Trial end date: 2013-06-01

Summary

This study demonstrates the effect of generic clopidogrel bisulfate (Plavitor®) in comparison with the original clopidogrel bisulfate (Plavix®) in patients with acute coronary syndrome.

• Phase: Phase 4

Details

• Lead Sponsor: Ajou University School of Medicine
• Collaborators: Dong-A Pharmaceutical; Dong-A Pharmaceutical Corporation
• Treatments: Clopidogrel; Ticlopidine